Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study

Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study

Abstract Aim Metabolic dysfunction-associated steatotic disease (MASLD) and chronic hepatitis B (CHB) are prevalent liver disorders. Ongoing discussions investigate the impact of MASLD on the therapeutic outcomes of CHB. Methods A cohort of 320 CHB patients on antiviral therapy (including NAs and PE...

Full description

Saved in:
Bibliographic Details
Main Authors: Guanghui Ren, Kaining Jia, Shi Yin, Yunpeng Guan, Qingwei Cong, Ying Zhu
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Virology Journal
Subjects:
Hepatic steatosis
Chronic hepatitis B
HBsAg
Antiviral treatment
Predictive model
Online Access:https://doi.org/10.1186/s12985-025-02642-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12985-025-02642-9

Similar Items